PRODUCT VANTIX PRODUCT

SUPPORT VANTIX SUPPORT

Sejong News

2020.12.01 The 21st Korea Packaging Machinery Association Award Ceremony Sejong Pharmatech Co., Ltd. won the 21st Packaging Machinery Awards hosted by the Korea Packaging Machinery Association. The Korea Packaging Machinery Awards have been awarded every year by selecting CEOs and workers of packaging machines and related companies that showed outstanding performance in each field, including technology development, quality improvement, business administration, and export sales in the packaging machine industry. On behalf of Sejong Pharmatech, Choi Soo-young, resercher was honored it this year.   http://www.yakup.com/news/index.html?mode=view&pmode=&cat=&cat2=&nid=251706&num_start=0&csearch_word=%EC%84%B8%EC%A2%85%ED%8C%8C%EB%A7%88%ED%85%8D&csearch_type=&cs_scope   more +
2020.11.30 Sejong Pharmatech has achieved a K-mark certificate for 'VANTIX P420S WIP'. It was selected as an excellent R&D innovation product designated by the Ministry of SMEs and Venture Business in 2020. continuing from that, we achieved a K-mark certificate in November. K-mark certificate is a certification policy that is given to products that pass the performance standards of the Korea Testing Laboratory. The VANTIX P420S WIP has been proven to meet performance standard for the first time in Korea.  The VANTIX P420S WIP model is the first rotary type tablet pressing machine equipped with a high-contained and internal negative- pressurized system to minimize the risk of workers being exposed to raw pharmaceutical ingredients, which is designed to be open and closed the door after the removal hazardous factors through cleaning cycle process (WIP – Washing In Place) after the completion of production process.   Unlike the subjective proof data presented by ordinary manufacturers, it is significant that it has been objectively certified the newly developed P420S WIP performance by KTL which is a third party with public confidence.   more +
2020.11.09 Sejong Pharmatech launched the first "Hard Capsules Liquid Filling Machine F50" in Korea The global market for highly potent active pharmaceutical ingredients (HPAPIs) is expanding at, or near, double-digit rates according to various market research firms. This demand has been driven by factors such as the rising incidence of cancer worldwide, an aging global population and increases in associated age-related diseases. Perhaps equally important is the advances in our knowledge about disease modalities. Greater understanding of disease mechanism is leading to the development of next-generation medicines, including highly potent drugs with the ability to achieve targeted delivery. Formulating HPAPIs as liquids(liquid form, Semi-Solid form) rather than powders provides many benefits with respect to the simplification of drug manufacturing processes. liquid-base HPAPI formulations require less stringent controls during the preparation of final dosage forms than tablet compression and solid form encapsulation, which results in greater efficacy and safety, as well as a reduction in side effects. Liquid Encapsulation Technology (LET) is one of the most promising and cost-effective strategies to address the multiple physicochemical challenges associated with the use of nutraceutical ingredients. The most important advantage of these capsules is their ability to formulate compounds with poor solubility. Additionally, they can help accelerate the speed to market by providing the flexibility to rapidly develop and test formulations in-house at R&D and large scale. Sejong Pharmatech Co., Ltd., Korea's leading manufacturer of pharmaceutical machineries, quickly grasped the market needs and manufacturing technology trends of pharmaceutical manufacturing processes and launched the Vantix F50 Liquid Filling model for the first time in Korea this year. Vantix F50 Liquid Filling machine can not only fill the liquid-base hard-capsule but also fill the solid-formulation (Solid Formulation) and the Multi-Dosing combined with the liquid formulation, such as powder, pellet and Tablet/mini-Tablet.   -> Detailed function of Vantix F50 Liquid Filling model can be checked in the video clip below or on our website. https://www.youtube.com/watch?v=qERaNB_Gofo   -> Posted the related article in YAKUP news website. http://www.yakup.com/news/index.html?mode=view&cat=12&nid=251107   more +
PRIVACY STATEMENT
Sejong Pharmatech Co., Ltd. (hereinafter “Company”) puts emphasis on personal information and complies with the “Act on Promotion of Information and Communications Network Utilization and Information Protection, Etc.” Through the policy on handling personal information, Company will notify how and in what way the personal information that the customers provide are being used and what measures are being taken to protect personal information. In case Company amends the policy on handing personal information, Company will notify it through its Web site (or individually).This policy shall take effect starting October 10, 2014.

Items of personal information to be collected
Company collects personal information for application for subscription, consultation, services, etc.
• Items for collection : name, home telephone number, home address, cell phone number, and e-mail
• Method of collecting personal information : Web site (online job application)

Collection and purpose of use of personal information

Company uses personal information collected for the following purpose.
• identification for the responses of customers’ inquiry
• notification of the result

Period of keeping and using personal information
After the collection of personal information and the purpose of use has been achieved, Company destroys the said information in due time.

Destruction process and method of personal information
After the collection of personal information and the purpose of use has been achieved, Company destroys the said information in due time. The destruction process and the method are as follows.

Destruction process
Information members who have put for subscription purpose, etc ., will be moved to a separate database (separate cabinet in case of papers) after the purpose of information has been achieved and shall be kept for a certain period and be destroyed pursuant to the policies to protect personal information (refer to keeping and using period) according to the internal policy and other laws. 
Personal information that has been moved to a separate database will not be used for any purpose other than that stated under the laws and for storage.

Destruction method
The personal information will be deleted in the database.

Furnishing personal information
In principle, Company does not provide users’ personal information to outsiders. However, the following shall be an exception.
• Users have given prior consent.
• Stipulated under the laws or upon request by the investigating agency pursuant to the process and method as set under the laws for the investigation purpose

Entrustment of personal information
Company does not entrust the customer’s personal information to the outsider without the customer’s consent. If it is subsequently necessary to do so, Company will notify the customer about the entrustment target and the contents of the entrustment business, and will obtain prior consent if necessary.

Rights of users and their legal representatives, and methods for exercising such rights
Users and legal representatives can refer or amend the personal information of the registered self and a child of less than 14 years, and may request the cancellation of subscription anytime. For referring and amending the personal information of the user or a child of less than 14 years, users can go through the ID checking process by clicking “Change of personal information” (or “Change of member information”) for amending the personal information and “Quitting membership” in case of subscription cancellation (withdrawing consent), and may directly read, amend, or quit the membership. Users may also contact the staff in charge of personal information management in writing, by telephone, or via e-mail, and shall be taken care without delay.

If you have requested to correct the error in personal information, the personal information will not be used or furnished until the correction has been completed. If incorrect personal information has been furnished to a third party, Company shall notify the handling result of the correction to the third party without delay and shall make sure that the correction will be performed.

Personal information that has been cancelled or deleted upon the request of the user or a legal representative will be handled in accordance with the rules under “Period of keeping and using the personal information collected by Company” and is handled in a way in which it cannot be read or used for other purposes.
Matters concerning the installation, operation, and denial of a device that automatically collects personal information
Company does not operate a device that automatically collects personal information when using the Internet, such as cookies, etc.

Civil service regarding personal information
Company designates the team indicated below to protect customer’s personal information and handle customer’s complaints with regard to personal information.
Customer service and personal information management team: Plannig team Team at Sejong Pharmatech  Co., Ltd.
• Tel : +82-32-508-1284
• E-mail : plan@sjpmt.com
You can file any complaints with regard to personal information that would arise during the use of Company’s service to the relevant team. Company will promptly give a sufficient answer for the user’s complaint.
Please inquire to the following agencies if you need to report an infringement on personal information or for consultation.
• Personal Information Dispute Mediation Committee (www.1336.or.kr/1336)
• Information Protection Mark Authentication Committee (www.eprivacy.or.kr/+82-2-580-0533~4)
• Supreme Prosecutor’s Office Internet Crime Investigation Center (http://icic.sppo.go.kr/+82-2-3480-3600)
• Korea National Policy Agency Cyber Bureau (www.ctrc.go.kr/+82-2-392-0330)

LOGIN

Please enter ID and password.
If you need any help please contact 1544-5840

Catalog Request

Privacy Policy

Sejong Pharmatech's Privacy Protection Policy

We understand the importance of protecting the personal information of our customers and our employees. In addition, we are constantly looking for new and better ways to secure your personal information and to ensure that it is used in a responsible and respectful manner.

If you have questions or complaints regarding our privacy policy or practices, you should first contact Sejong Pharmatech's Office as follows:

Sejong Pharmatech Office
#63, AnNam 402 Road, Bupyeong-Gu, Incheon City, Korea(403-030)
I agree with Sejong’s personal information handling policy.